Europe Dementia Treatment Market

Europe Dementia Treatment Market Size, Share & Trends Analysis Report By Type, By Dementia Drugs Route of Administration (Oral, Transdermal Patch, and Injectable), By Dementia Drugs Distribution Channel, By Indication, By Country and Growth Forecast, 2024 - 2031

Report Id: KBV-23206 Publication Date: June-2024 Number of Pages: 172
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Europe Dementia Treatment Market would witness market growth of 7.0% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Dementia Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,884.6 million by 2031. The UK market is exhibiting a CAGR of 6.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.8% during (2024 - 2031).

Europe Dementia Treatment Market

The economic impact of dementia is substantial, affecting not only individuals and families but also healthcare systems and societies at large. The cost of dementia care includes direct medical expenses, such as hospitalizations, medications, and long-term care, as well as indirect costs, such as lost productivity and informal caregiving.

The increasing prevalence of dementia is a primary driver of the growth in the dementia treatment market. In addition, developments in medical research and technology are serving as a driving force behind the market. Continuous research into the underlying mechanisms of dementia has led to the development of innovative therapeutic approaches, including disease-modifying therapies and targeted treatments.

Italy is experiencing significant demographic changes due to its rapidly aging population. The median age of Italy's population is one of the highest in Europe, and the proportion of elderly individuals is anticipated to continue increasing in the subsequent decades. The increasing incidence of dementia in the region has led to a greater emphasis on developing effective treatment strategies and enhancing healthcare infrastructure to manage the growing number of dementia patients. Thus, all the aforementioned elements will support the expansion of the market in the coming years.

Free Valuable Insights: The Global Dementia Treatment Market will Hit USD 29.2 Billion by 2031, at a CAGR of 7.4%

Based on Type, the market is segmented into Diagnosis (Imaging Techniques, Cognitive Assessment Tools, Genetic Testing, Biomarker Analysis and Others) and Drugs (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug and Others). Based on Dementia Drugs Route of Administration, the market is segmented into Oral, Transdermal Patch, and Injectable. Based on Dementia Drugs Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Indication, the market is segmented into Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Eisai Co., Ltd.
  • Eli Lilly And Company
  • F.Hoffmann-La Roche Ltd.
  • Biogen, Inc.
  • AbbVie, Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • GlaxoSmithKline PLC (GSK)
  • Cipla Limited

Europe Dementia Treatment Market Report Segmentation

By Type

  • Diagnosis
    • Imaging Techniques
    • Cognitive Assessment Tools
    • Genetic Testing
    • Biomarker Analysis
    • Others
  • Drugs
    • Cholinesterase Inhibitors
    • NMDA Receptor Antagonist
    • MAO Inhibitors
    • Combination Drug
    • Others

By Dementia Drugs Route of Administration

  • Oral
  • Transdermal Patch
  • Injectable

By Dementia Drugs Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Indication

  • Alzheimer’s Disease Dementia
  • Vascular Dementia
  • Lewy Body Dementia
  • Frontotemporal Dementia (FTD)
  • Parkinson Disease Dementia
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo